Thibaud Valentin

1.1k total citations
38 papers, 505 citations indexed

About

Thibaud Valentin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Thibaud Valentin has authored 38 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Thibaud Valentin's work include Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cardiac tumors and thrombi (6 papers). Thibaud Valentin is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Vascular Tumors and Angiosarcomas (8 papers) and Cardiac tumors and thrombi (6 papers). Thibaud Valentin collaborates with scholars based in France, Spain and Italy. Thibaud Valentin's co-authors include Sophie Le Guellec, Nicolas Penel, Nicolás Isambert, Christine Chevreau, Emmanuelle Bompas, Antoîne Italiano, Frédéric Chibon, Tom Lesluyes, François Bertucci and Axel Le Cesne and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer.

In The Last Decade

Thibaud Valentin

34 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thibaud Valentin France	12	324	202	124	107	83	38	505
Jasmien Cornillie Belgium	14	330 1.0×	211 1.0×	65 0.5×	66 0.6×	84 1.0×	27	471
Javier Lavernia Spain	13	247 0.8×	181 0.9×	50 0.4×	179 1.7×	74 0.9×	53	527
Daniela Katz Israel	12	365 1.1×	323 1.6×	103 0.8×	74 0.7×	161 1.9×	29	620
Markus P. Ghadimi Germany	13	478 1.5×	235 1.2×	73 0.6×	84 0.8×	176 2.1×	28	665
Ghadah Al Sannaa United States	12	333 1.0×	151 0.7×	239 1.9×	110 1.0×	79 1.0×	18	555
Jorge Torres‐Mora United States	10	189 0.6×	154 0.8×	114 0.9×	106 1.0×	40 0.5×	38	527
Thomas Ryckewaert France	12	473 1.5×	378 1.9×	70 0.6×	177 1.7×	87 1.0×	36	725
Myrella Vlenterie Netherlands	11	407 1.3×	245 1.2×	49 0.4×	86 0.8×	124 1.5×	15	526
Kelsey L. Watson United States	9	267 0.8×	111 0.5×	185 1.5×	77 0.7×	66 0.8×	10	403
Takahiro Tajino Japan	15	394 1.2×	109 0.5×	70 0.6×	97 0.9×	60 0.7×	35	641

Countries citing papers authored by Thibaud Valentin

Since Specialization

Citations

This map shows the geographic impact of Thibaud Valentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thibaud Valentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thibaud Valentin more than expected).

Fields of papers citing papers by Thibaud Valentin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thibaud Valentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thibaud Valentin. The network helps show where Thibaud Valentin may publish in the future.

Co-authorship network of co-authors of Thibaud Valentin

This figure shows the co-authorship network connecting the top 25 collaborators of Thibaud Valentin. A scholar is included among the top collaborators of Thibaud Valentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thibaud Valentin. Thibaud Valentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chibon, Frédéric, et al.. (2025). 82P Advancing precision oncology in soft tissue sarcomas: The role of iTRAC in metastatic risk stratification and treatment personalization. ESMO Open. 10. 104395–104395.

Sargos, Paul, M.-P. Sunyach, Anne Ducassou, et al.. (2025). Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study. Annals of Oncology. 36(5). 592–600. 1 indexed citations

Toulmonde, Maud, Mariella Spalato Ceruso, Thibaud Valentin, et al.. (2025). Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab. Signal Transduction and Targeted Therapy. 10(1). 202–202. 2 indexed citations

Ferron, Gwénaël, Guillaume Bataillon, Alejandra Martínez, Frédéric Chibon, & Thibaud Valentin. (2024). Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease. International Journal of Gynecological Cancer. 34(3). 393–402. 4 indexed citations

Chaltiel, Léonor, M. Thoulouzan, Nicolas Carrère, et al.. (2023). Survival analysis and prognostic factors of retroperitoneal liposarcoma curative surgery in a single centre. Analysis of adjacent organ invasion between imaging and definitive histopathology. Surgical Oncology. 49. 101950–101950. 1 indexed citations

Feng, Xiaolan, Laurie Tonon, Haocheng Li, et al.. (2023). Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers. 15(14). 3705–3705. 6 indexed citations

Valentin, Thibaud, Marie Lambert, Léonor Chaltiel, et al.. (2023). Population pharmacokinetic analysis reveals no impact of aprepitant on the pharmacokinetics of ifosfamide, 2-dechloroifosfamide, and 3-dechloroifosfamide. European Journal of Pharmaceutical Sciences. 185. 106420–106420.

Valentin, Thibaud, Delphine Bonnet, Frédéric Chibon, et al.. (2023). Special features of sarcomas developed in patients with Lynch syndrome: A systematic review. Critical Reviews in Oncology/Hematology. 188. 104055–104055. 4 indexed citations

Reich, M., Juliane Berchoud, Myriam Jean‐Denis, et al.. (2023). 1971P Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study. Annals of Oncology. 34. S1053–S1053.

10.

Chen, Tom Wei‐Wu, A. Le Cesne, Antoîne Italiano, et al.. (2022). Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan. Cancer. 128(18). 3360–3369. 3 indexed citations

11.

Mourey, Loı̈c, Alain Ravaud, Laurence Digue, et al.. (2021). VOTRAGE study: Phase I dose-escalation study of pazopanib in unfit older patients. Journal of Geriatric Oncology. 12(5). 759–764. 4 indexed citations

12.

Lesluyes, Tom, Christine Ménétrier‐Caux, Mehdi Brahmi, et al.. (2020). Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma. OncoImmunology. 9(1). 1792036–1792036. 30 indexed citations

13.

Constantinidou, Anastasia, Nicolas Sauvé, Silvia Stacchiotti, et al.. (2020). Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study. ESMO Open. 5(4). e000787–e000787. 26 indexed citations

14.

Filleron, Thomas, Sophie Le Guellec, Christine Chevreau, et al.. (2020). Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial. BMC Cancer. 20(1). 716–716. 9 indexed citations

15.

Guellec, Sophie Le, Tom Lesluyes, Thomas Filleron, et al.. (2018). Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas. Annals of Oncology. 29(8). 1828–1835. 25 indexed citations

16.

Elez, Élena, Carlos Gomez‐Roca, Guillem Argilés, et al.. (2018). First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors. Investigational New Drugs. 37(4). 674–683. 18 indexed citations

17.

Valentin, Thibaud, Axel Le Cesne, Isabelle Ray‐Coquard, et al.. (2016). Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). European Journal of Cancer. 56. 77–84. 110 indexed citations

18.

Cesne, Axel Le, Jean‐Yves Blay, Julien Dômont, et al.. (2015). Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial. The Lancet Oncology. 16(3). 312–319. 63 indexed citations

19.

Hoareau‐Aveilla, Coralie, Thibaud Valentin, Cathy Quelen, et al.. (2015). Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth. Journal of Clinical Investigation. 125(9). 3505–3518. 34 indexed citations

20.

Valentin, Thibaud, Charles Fournier, Nicolas Penel, et al.. (2013). Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO). Investigational New Drugs. 31(6). 1626–1627. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact